The 20 Best Carnitine Palmitoyltransferase 2 Deficiency Doctors Near Me in Ann Arbor, MI

Dr. Pritchard is a Michigan native who returned to the University of Michigan to join the faculty here in 2019 after completing her pediatrics and genetics residencies and biochemical genetics fellowship. She enjoys care of complex patients with rare genetic diseases. Dr. Pritchard is active in medical education as Program Director for the Medical Biochemical Genetics Fellowship program and Associate Program Director for the Medical Genetics and Genomics training programs.Outside of work, Dr. Pritchard enjoys cooking, reading, hiking, and spending time with her husband and two daughters. Dr. Pritchard is rated as an Advanced provider by MediFind in the treatment of Carnitine Palmitoyltransferase 2 Deficiency. She is also highly rated in 149 other conditions, according to our data. Her clinical expertise encompasses Microcephaly Deafness Syndrome, Propionic Acidemia, Delayed Growth, and Cohen Syndrome.

Ayesha Ahmad is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Ahmad is rated as an Advanced provider by MediFind in the treatment of Carnitine Palmitoyltransferase 2 Deficiency. She is also highly rated in 50 other conditions, according to our data. Her clinical expertise encompasses Pompe Disease, Propionic Acidemia, Von Gierke Disease, and Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome). Dr. Ahmad is board certified in Clinical Biochemical Genetics and Clinical Genetics & Genomics.

Laura Mariani is an Internal Medicine specialist and a Nephrologist practicing medicine in Ann Arbor, Michigan. Dr. Mariani is rated as an Advanced provider by MediFind in the treatment of Carnitine Palmitoyltransferase 2 Deficiency. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Minimal Change Disease, Glomerulonephritis, Carnitine Palmitoyltransferase 2 Deficiency, and Thin Basement Membrane Nephropathy.

Dr. DiMagno grew up in southern Illinois and completed her undergraduate studies in Biology at Washington University in St. Louis. She earned her medical degree from the University of Illinois at Chicago and completed her Internal Medicine residency at the University of Michigan in 1998. She is board certified in Internal Medicine.She joined the faculty at Michigan Medicine in 1998 and spent 20 years practicing Primary Care General Internal Medicine at the Brighton Health Center. In 2018, she became part of the founding team of the newly opened Victors Care program, where she continues to provide personalized, relationship-based care. She was appointed Medical Director in 2021.Her clinical interests include patient-physician communication, preventive care, women’s health, and behavior change in chronic disease. A longtime educator of medical students and residents, Dr. DiMagno brings that experience into her practice through clear communication and shared decision-making. She emphasizes personalized, evidence-informed care grounded in trust, continuity, and a desire to understand each patient’s values and goals.She and her husband, Matthew, have four children, now ranging from middle school through college. Much of her free time is spent cheering them on from the sidelines of hockey, soccer, and lacrosse—hockey remains her favorite. She has played recreational hockey since her daughter first took up the sport and continues to enjoy the game. She also enjoys supporting her children’s musical performances and spending time outdoors and with family. Dr. Dimagno is rated as an Advanced provider by MediFind in the treatment of Carnitine Palmitoyltransferase 2 Deficiency. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Carnitine Palmitoyltransferase 2 Deficiency, Carnitine Palmitoyltransferase 1 Deficiency, Bloom Syndrome, and Urticaria Pigmentosa. Dr. Dimagno is board certified in Internal Medicine.

Dr. Feldman is the director of the NeuroNetwork for Emerging Therapies at Michigan Medicine and the ALS Center of Excellence at Michigan Medicine. The latter includes the Pranger ALS Clinic, one of the top multidisciplinary clinics caring for those suffering from amyotrophic lateral sclerosis (ALS). She serves as the University of Michigan James W. Albers Distinguished University Professor and the Russell N. DeJong Professor of Neurology at Michigan Medicine. Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease.Dr. Feldman is a compassionate and dedicated physician who cares deeply about her patients. She has been recognized for her clinical excellence by numerous organizations and is annually named as one of the “Best Doctors in America.” Her forward-thinking, collaborative, multidisciplinary approach has transformed how neurodegenerative diseases are diagnosed, treated, and prevented.Dr. Feldman has made significant contributions to biomedical research and clinical care in many critical areas of neurodegenerative disease. She has authored over 530 peer-reviewed publications, 74 book chapters, and 5 books on the pathology, diagnosis, and treatment of neurological diseases. Dr. Feldman has been continuously funded by the NIH since 1989 and is currently the principal or co-investigator of numerous clinical trials and grants. She has received numerous awards and honors throughout her remarkable career, including the University of Michigan’s Early Distinguished Career Award, the Distinguished Faculty Achievement Award, and the Distinguished Alumnus Achievement Award. She was also the first woman in 25 years to receive the Robert S. Schwab Award from the American Clinical Neurophysiology Society. In 2022, Dr. Feldman was awarded the University of Michigan Distinguished Professorship, the highest faculty honor at University of Michigan.Dr. Feldman is actively committed to and involved in professional service. She served as President of the Peripheral Nerve Society from 2007-2009 and President of the American Neurological Association (ANA) from 2011-2013. Dr. Feldman is an elected member of the National Academy of Medicine (NAM) and Association of American Physicians, and a Fellow of the American Association for the Advancement of Science. Dr. Feldman is the Editor of the Contemporary Neurology Series and also serves on a number of editorial boards for leading scientific journals, including The Lancet Neurology, Nature Reviews Neurology, JAMA Neurology and Journal of Neurology, Neurosurgery and Psychiatry. Dr. Feldman is rated as an Experienced provider by MediFind in the treatment of Carnitine Palmitoyltransferase 2 Deficiency. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Peripheral Neuropathy, Diabetic Neuropathy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Autonomic Neuropathy. Dr. Feldman is board certified in Neurology and Electrodiagnostic Medicine.

Tomoyasu Higashimoto is a Medical Genetics specialist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Higashimoto is rated as an Experienced provider by MediFind in the treatment of Carnitine Palmitoyltransferase 2 Deficiency. He is also highly rated in 110 other conditions, according to our data. His clinical expertise encompasses Nevoid Basal Cell Carcinoma Syndrome, Methylmalonic Acidemia, Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, and Propionic Acidemia. Dr. Higashimoto is board certified in Family Medicine and Clinical Genetics & Genomics.

Cooking, spending time with my family. Dr. Ames is rated as an Experienced provider by MediFind in the treatment of Carnitine Palmitoyltransferase 2 Deficiency. She is also highly rated in 115 other conditions, according to our data. Her clinical expertise encompasses Delayed Growth, Cardiomyopathic Lentiginosis, Cardiofaciocutaneous Syndrome, and Noonan Syndrome. Dr. Ames is board certified in Pediatrics, Clinical Genetics & Genomics, and Medical Biochemical Genetics.